Choose Your Country or Region

Dasatinib Monohydrate

Name: Dasatinib Monohydrate
Brand: Selleck Chemicals
SKU: S7782
Rating: 5 (232 reviews)

Catalog No.S7782 Synonyms: BMS-354825 Monohydrate

For research use only.

Dasatinib Monohydrate (BMS-354825) is a novel, potent and multi-targeted inhibitor that targets Abl, Src and c-Kit, with IC50 of <1 nM, 0.8 nM and 79 nM, respectively.

Dasatinib Monohydrate Chemical Structure

CAS No. 863127-77-9

Selleck's Dasatinib Monohydrate has been cited by 232 publications

Purity & Quality Control

Choose Selective Src Inhibitors

Related Compound Libraries

Other Src Products

SU6656^New

SU 6656 is a selective Src family kinase inhibitor with IC50 of 280 nM, 20 nM, 130 nM, and 170 nM for Src, Yes, Lyn, and Fyn, respectively.
PX-478 2HCl^New

PX-478 2HCl is an orally active, and selective hypoxia-inducible factor-1α (HIF-1α) inhibitor. PX-478 2HCl induces apoptosis and has anti-tumor activity. Phase 1.
Defactinib (VS-6063)^New

Defactinib (VS-6063, PF-04554878) is a selective, and orally active FAK inhibitor. Phase 2.
Saracatinib (AZD0530)

Saracatinib (AZD0530) is a potent Src inhibitor with IC50 of 2.7 nM in cell-free assays, and potent to c-Yes, Fyn, Lyn, Blk, Fgr and Lck; less active for Abl and EGFR (L858R and L861Q). Saracatinib induces autophagy. Phase 2/3.
Bosutinib (SKI-606)

Bosutinib (SKI-606) is a novel, dual Src/Abl inhibitor with IC50 of 1.2 nM and 1 nM in cell-free assays, respectively. Bosutinib also effectively decreases the activity of PI3K/AKT/mTOR, MAPK/ERK and JAK/STAT3 signaling pathways by blocking the phosphorylation levels of p-ERK, p-S6, and p-STAT3. Bosutinib promotes autophagy.
Dasatinib (BMS-354825)

Dasatinib (BMS-354825) is a novel, potent and multi-targeted inhibitor that targets Abl, Src and c-Kit, with IC50 of <1 nM, 0.8 nM and 79 nM in cell-free assays, respectively. Dasatinib induces autophagy and apoptosis with anti-tumor activity.
KX2-391 (Tirbanibulin)

KX2-391, the first clinical Src inhibitor (peptidomimetic class) that targets the peptide substrate site of Src, with GI50 of 9-60 nM in cancer cell lines. Phase 2.
PP1

PP1 (AGL 1872, EI 275) is a potent and selective Src inhibitor for Lck/Fyn with IC50 of 5 nM/ 6 nM.
PP2

PP2 (AG 1879, AGL 1879), a Src family kinase inhibitor, potently inhibits Lck/Fyn with IC50 of 4 nM/5 nM in cell-free assays, ~100-fold less potent to EGFR, inactive for ZAP-70, JAK2 and PKA.
WH-4-023

WH-4-023 (KIN001-112, KIN112, Dual LCK/SRC inhibitor) is a potent and orally active Lck/Src inhibitor with IC50s of 2 nM and 6 nM in cell-free assays, respectively. Exhibits >300-fold selectivity against p38α and KDR. Also potently inhibits SIK (IC50 values are 10, 22 and 60 nM for SIK 1, 2 and 3 respectively) and displays selectivity over a range of closely related kinases.

Download Inhibitor Catalog

Src Signaling Pathway Map

Biological Activity

Description

Dasatinib Monohydrate (BMS-354825) is a novel, potent and multi-targeted inhibitor that targets Abl, Src and c-Kit, with IC50 of <1 nM, 0.8 nM and 79 nM, respectively.

Targets

Abl ^[1] (Cell-free assay)	Src ^[1] (Cell-free assay)	c-Kit (D816V) ^[2] (Cell-free assay)	c-Kit (wt) ^[2] (Cell-free assay)
0.6 nM	0.8 nM	37 nM	79 nM

In vitro

Dasatinib is more effective than imatinib in inhibiting the proliferation of Ba/F3 cells expressing wild-type Bcr-Abl and Bcr-Abl mutants, with the exception of T315I. Dasatinib has a two-log (∼325-fold) increased potency relative to imatinib. Dasatinib potently inhibits wild-type Abl kinase and all mutants except T315I over a narrow range. Dasatinib directly targets wild-type and mutant Abl kinase domains and inhibits autophosphorylation and substrate phosphorylation in a concentration-dependent manner. Dasatinib displays 325-fold greater potency compared with imatinib against cells expressing wild-type Bcr-Abl. ^[1] The percent of colonies of TgE bone marrow cells are decreased from 100% in untreated wells to 4.12% in Dasatinib treated wells. In the presence of Dasatinib, the difference in the percentage of colonies formed by WT and TgE bone marrow cells is statistically significant. Expression of LMP2A is able to promote B lymphocyte survival and proliferation, which can be inhibited by targeting Lyn and/or c-Abl kinases through Dasatinib. ^[3] Dasatinib treatment inhibits Src signaling, decreases growth, and induces cell cycle arrest and apoptosis in a subset of thyroid cancer cells. Treatment with increasing doses of Dasatinib (0.019 μM to 1.25 μM) for 3 days inhibits the growth of the C643, TPC1, BCPAP, and SW1736 cell lines by about 50% at low nanomolar concentrations, while higher concentrations are required to inhibit the growth of the K1 cell line. Treatment with 10 nM or 50 nM Dasatinib results in a 9-22% increase of cells in the G1 population among BCPAP and SW1736 and K1 cells, and a corresponding 7-18% decrease in the percentage of cells in the S phase. ^[4]

Cell Data

Cell Lines	Assay Type	Concentration	Incubation Time	Formulation	Activity Description	PMID

K562 cell	MlzQVJJwdGmoZYLheIlwdiCjc4PhfS=>	M2fJNVczKGh?	NXTTWY17SW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDLOVYzKGOnbHzzJIFnfGW{IEeyJIhzeyxiSVO1NF0xNjByMTFOwG0>	NWLZWIZTOTV4MUW1NVI>
WiDr cell	NFnUVIZRem:uaX\ldoF1cW:wIHHzd4F6	M3noXlczKGh?	MWPBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKFerRIKgZ4VtdHNiYX\0[ZIhPzJiaILzMEBKSzVyPUCuNFUzKM7:TR?=	MnfiNVU3OTV3MUK=
PC3 cell	MVzQdo9tcW[ncnH0bY9vKGG\|c3H5	MYC3NkBp	MX;BcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKFCFMzDj[YxteyCjZoTldkA4OiCqcoOsJGlEPTB;MD6wNFk1KM7:TR?=	MX:xOVYyPTVzMh?=
MDA-MB-231 cell	MmHPVJJwdGmoZYLheIlwdiCjc4PhfS=>	MmL3O\|IhcA>?	NGPHSoRCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIF3ERU1OSi1{M{GgZ4VtdHNiYX\0[ZIhPzJiaILzMEBKSzVyPUCuNFEzKM7:TR?=	NFzUV5IyPTZzNUWxNi=>
M07ep210 cell	NGn4U4hIem:5dHigbY5pcWKrdHnvckBie3OjeR?=	NV;mUZJbPDhiaB?=	NXPNVoVuT3Kxd4ToJIlvcGmkaYTpc44hd2ZiaIXtZY4hVTB5ZYCyNVAh[2WubIOgZYZ1\XJiNEigbJJ{KGK7IGuzTH11cHmvaXTpcoUhfXC2YXvlJIF{e2G7LDDJR\|UxRTBwMEegcm0>	NYPrcmt4OTd7NU[wPFA>
K562 cell	NWOxOZRXT3Kxd4ToJIlvcGmkaYTpc44h[XO\|YYm=	M2Ww[FQ5KGh?	MljRS5Jwf3SqIHnubIljcXSrb36gc4YhcHWvYX6gT\|U3OiClZXzsd{Bi\nSncjC0PEBpenNiYomgX\|NJZXSqeX3p[Ilv\SC3cIThb4Uh[XO\|YYmsJGlEPTB;MD6wNFEh\|ryP	M4C2Z\|E4QTV4MEiw
M07e cell	MoTJS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl?	MX:0PEBp	M3\NWmdzd3e2aDDpcohq[mm2aX;uJI9nKGi3bXHuJG0xP2ViY3XscJMh[W[2ZYKgOFghcHK\|IHL5JHs{UF22aIntbYRqdmVidYD0ZYtmKGG\|c3H5MEBKSzVyPUCuNFAyOiEQvF2=	MkTiNVc6PTZyOEC=
K562 cell	M1P0ZmN6fG:2b4jpZ4l1gSCjc4PhfS=>	NYrmOmFrPzJiaB?=	M2LybWN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGs2PjJiY3XscJMh[W[2ZYKgO\|IhcHK\|IHL5JHdUXC16IILlZYdmdnRiYnHz[YQhVVSWIHHzd4F6NCCLQ{WwQVEzNjh\|IN88US=>	NUPkRYxbOjJ{MUe4O\|c>
U937 cell	MmTrR5l1d3SxeHnjbZR6KGG\|c3H5	MUm3NkBp	NFrmd\|lEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBWQTN5IHPlcIx{KGGodHXyJFczKGi{czDifUBYW1RvODDy[YFo\W62IHLhd4VlKE2WVDDhd5NigSxiSVO1NF0yOy54MzFOwG0>	MnKyNlIzOTd6N{e=
K562 cell	NYm3RWV2WHKxbHnm[ZJifGmxbjDhd5NigQ>?	MmSyO\|IhcA>?	MmiwRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6\|dDDoeY1idiCNNU[yJINmdGy\|IHHmeIVzKDd{IHjyd{BjgSCFQ1u4JIF{e2G7LDDJR\|UxRTBwNzDuUS=>	MlzLNlM2OjFyMkC=
MDA-MB-435S cell	MVvQdo9tcW[ncnH0bY9vKGG\|c3H5	MkT5O\|IhcA>?	MXHBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKE2GQT3NRk01OzWVIHPlcIx{KGGodHXyJFczKGi{czDifUBOXFRiYYPzZZktKEmFNUC9N{46KM7:TR?=	M1jwUFI{PTJzMEKw
NCI-H460 cell	MorEVJJwdGmoZYLheIlwdiCjc4PhfS=>	MU[3NkBp	M2\Qd2FvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iTlPJMWg1PjBiY3XscJMh[W[2ZYKgO\|IhcHK\|IHL5JG1VXCCjc4PhfUwhUUN3ME24Mlk6KM7:TR?=	MUSyN\|UzOTB{MB?=
NCI-H23 cell	MXnQdo9tcW[ncnH0bY9vKGG\|c3H5	MXW3NkBp	M4e1SGFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iTlPJMWgzOyClZXzsd{Bi\nSncjC3NkBpenNiYomgUXRVKGG\|c3H5MEBKSzVyPUKuNlch\|ryP	MmXuNlM2OjFyMkC=
A549 cell	M1\aNnBzd2yrZnXyZZRqd25iYYPzZZk>	MYq3NkBp	M2LHOmFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iQUW0PUBk\WyuczDh[pRmeiB5MjDodpMh[nliTWTUJIF{e2G7LDDJR\|UxRTF{Lk[2JO69VQ>?	MXeyN\|UzOTB{MB?=
T47D cell	NGTMR45Rem:uaX\ldoF1cW:wIHHzd4F6	MV:3NkBp	M4j1eGFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iVES3SEBk\WyuczDh[pRmeiB5MjDodpMh[nliTWTUJIF{e2G7LDDJR\|UxRTBwOTFOwG0>	MXWyN\|UzOTB{MB?=
HCT116 cell	MojpVJJwdGmoZYLheIlwdiCjc4PhfS=>	NE\CZ3k4OiCq	NVSzNI91SW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDIR3QyOTZiY3XscJMh[W[2ZYKgO\|IhcHK\|IHL5JG1VXCCjc4PhfUwhUUN3ME2yMlMh\|ryP	MYeyN\|UzOTB{MB?=
MCF7 cells	MWPQdo9tcW[ncnH0bY9vKGG\|c3H5	NGD5b4Y4OiCq	NHj2XmJCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIF3DSlch[2WubIOgZYZ1\XJiN{KgbJJ{KGK7IF3UWEBie3OjeTygTWM2OD1{LkW3JO69VQ>?	MomzNlM2OjFyMkC=
RXF 393NL cell	M37mXGN6fG:2b4jpZ4l1gSCjc4PhfS=>	NY\QbVJPPCCmYYnz	MUHDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDSXGYhOzl\|TlygZ4VtdHNiYX\0[ZIhPCCmYYnzJIJ6KHC{b4Dp[Il2dSCrb3Tp[IUhe3SjaX7pcoctKEmFNUC9NlEvPyCwTR?=	NXO0[5VnOjN{NUOwO\|Q>
PRXF DU145 cell	MWfDfZRwfG:6aXPpeJkh[XO\|YYm=	M1r6dFQh\GG7cx?=	M1nHcWN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJHBTYEZiRGWxOFUh[2WubIOgZYZ1\XJiNDDkZZl{KGK7IIDyc5Bq\Gm3bTDpc4Rq\GVic4ThbY5qdmduIFnDOVA:OC5yNkKzJO69VQ>?	NG\1XogzOzJ3M{C3OC=>
LXFA 983L cell	M3zFVWN6fG:2b4jpZ4l1gSCjc4PhfS=>	M37LW\|Qh\GG7cx?=	M2Phb2N6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGxZTkFiOUizUEBk\WyuczDh[pRmeiB2IHThfZMh[nlicILvdIllcXWvIHnv[Ill\SC\|dHHpcolv\yxiSVO1NF02Pi53IH7N	Ml3xNlMzPTNyN{S=
GXF251L cell	MYrDfZRwfG:6aXPpeJkh[XO\|YYm=	NHjpV3E1KGSjeYO=	MUDDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDHXGYzPTGOIHPlcIx{KGGodHXyJFQh\GG7czDifUBxem:yaXTpeY0hcW:maXTlJJN1[WmwaX7nMEBKSzVyPUKuNlUh\|ryP	MViyN\|I2OzB5NB?=
CXF 1103L cell	MXPDfZRwfG:6aXPpeJkh[XO\|YYm=	M{XLR\|Qh\GG7cx?=	M{D5dWN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGNZTiBzMUCzUEBk\WyuczDh[pRmeiB2IHThfZMh[nlicILvdIllcXWvIHnv[Ill\SC\|dHHpcolv\yxiSVO1NF01NjN4IN88US=>	NYDsOVFiOjN{NUOwO\|Q>
PAXF 1657L cell	MVLDfZRwfG:6aXPpeJkh[XO\|YYm=	MV60JIRigXN?	NE\veYNEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBRSViIIEG2OVdNKGOnbHzzJIFnfGW{IESg[IF6eyCkeTDwdo9xcWSrdX2gbY9lcWSnIIP0ZYlvcW6pLDDJR\|UxRTBwMUKxJO69VQ>?	NEXCZ3MzOzJ3M{C3OC=>
NCI-H1648 cell	M{S3Wmdzd3e2aDDpcohq[mm2aX;uJIF{e2G7		NFn1TYdKdmirYnn0bY9vKG:oIHj1cYFvKE6FST3INVY1QCClZXzsJIdzd3e2aDDpckBiKGOnbHygeoli[mmuaYT5JIF{e2G7LDDJR\|UxRTBwMEKwNVEh\|ryP	Ml\YV2FPT0WU
NCI-H1838 cell	NWDIOmJjT3Kxd4ToJIlvcGmkaYTpc44h[XO\|YYm=		MYnJcohq[mm2aX;uJI9nKGi3bXHuJG5EUS2KMUizPEBk\WyuIHfyc5d1cCCrbjDhJINmdGxidnnhZoltcXS7IHHzd4F6NCCLQ{WwQVEvOzB5M{Og{txO	NGfH[oVUSU6JRWK=
NCI-H2126 cell	MmTnS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl?		MlLwTY5pcWKrdHnvckBw\iCqdX3hckBPS0lvSEKxNlYh[2WubDDndo94fGhiaX6gZUBk\WyuII\pZYJqdGm2eTDhd5NigSxiSVO1NF0zNjh5NUWyJO69VQ>?	NXXlSmZLW0GQR1XS
NCI-H2141 cell	M1TMdGdzd3e2aDDpcohq[mm2aX;uJIF{e2G7		NFrIVJRKdmirYnn0bY9vKG:oIHj1cYFvKE6FST3INlE1OSClZXzsJIdzd3e2aDDpckBiKGOnbHygeoli[mmuaYT5JIF{e2G7LDDJR\|UxRTJ2Lke3OVQh\|ryP	M2TrdXNCVkeHUh?=
NCI-H2107 cell	NX3oTGlzT3Kxd4ToJIlvcGmkaYTpc44h[XO\|YYm=		M{fWdGlvcGmkaYTpc44hd2ZiaIXtZY4hVkOLLViyNVA4KGOnbHyg[5Jwf3SqIHnuJIEh[2WubDD2bYFjcWyrdImgZZN{[XluIFnDOVA:PDNwNEi0O{DPxE1?	M2nzbnNCVkeHUh?=
NCI-H747 cell	Moe2S5Jwf3SqIHnubIljcXSrb36gZZN{[Xl?		M{\mW2lvcGmkaYTpc44hd2ZiaIXtZY4hVkOLLVi3OFch[2WubDDndo94fGhiaX6gZUBk\WyuII\pZYJqdGm2eTDhd5NigSxiSVO1NF0xNjB6M{[yJO69VQ>?	NFfrXplUSU6JRWK=
NCI-H720 cell	NInGO29Iem:5dHigbY5pcWKrdHnvckBie3OjeR?=		NIDoNGtKdmirYnn0bY9vKG:oIHj1cYFvKE6FST3IO\|IxKGOnbHyg[5Jwf3SqIHnuJIEh[2WubDD2bYFjcWyrdImgZZN{[XluIFnDOVA:OjBwMkezN{DPxE1?	M{XKdXNCVkeHUh?=
NKM-1 cell	NWfWSlJZT3Kxd4ToJIlvcGmkaYTpc44h[XO\|YYm=		NUnRdZF5UW6qaXLpeIlwdiCxZjDoeY1idiCQS12tNUBk\WyuIHfyc5d1cCCrbjDhJINmdGxidnnhZoltcXS7IHHzd4F6NkmFNUC9NU4{ODh3OTFOwG0>	MXPTRW5ITVJ?
NMC-G1 cell	NVzISoNFT3Kxd4ToJIlvcGmkaYTpc44h[XO\|YYm=		NGjDWllKdmirYnn0bY9vKG:oIHj1cYFvKE6PQz3HNUBk\WyuIHfyc5d1cCCrbjDhJINmdGxidnnhZoltcXS7IHHzd4F6NkmFNUC9NE4yOTZyNjFOwG0>	M2Ltd3NCVkeHUh?=
NTERA-S-cl-D1 cell	MVvHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>?		NH;BWJJKdmirYnn0bY9vKG:oIHj1cYFvKE6WRWLBMXMu[2xvREGgZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfU5KSzVyPUCuNVIzQDNizszN	NHXSXGdUSU6JRWK=
OCI-AML2 cell	MnOzS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl?		NX32T3FKUW6qaXLpeIlwdiCxZjDoeY1idiCRQ1mtRW1NOiClZXzsJIdzd3e2aDDpckBiKGOnbHygeoli[mmuaYT5JIF{e2G7LlnDOVA:PS56NkG1OEDPxE1?	M3H6bXNCVkeHUh?=
OCUB-M cell	MVPHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>?		MXXJcohq[mm2aX;uJI9nKGi3bXHuJG9EXUJvTTDj[YxtKGe{b4f0bEBqdiCjIHPlcIwhfmmjYnnsbZR6KGG\|c3H5MmlEPTB;MT6wOFQyOiEQvF2=	NXvtWYV5W0GQR1XS
OPM-2 cell	MniwS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl?		M3XNTWlvcGmkaYTpc44hd2ZiaIXtZY4hV1CPLUKgZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfU5KSzVyPUSuNlc3QDVizszN	MVHTRW5ITVJ?
OS-RC-2 cell	M4P0fmdzd3e2aDDpcohq[mm2aX;uJIF{e2G7		MY\Jcohq[mm2aX;uJI9nKGi3bXHuJG9UNVKFLUKgZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfU5KSzVyPUCuNFIxOyEQvF2=	M{DFVnNCVkeHUh?=
ONS-76 cell	NGfL[49Iem:5dHigbY5pcWKrdHnvckBie3OjeR?=		NVKwd\|VnUW6qaXLpeIlwdiCxZjDoeY1idiCRTmOtO\|Yh[2WubDDndo94fGhiaX6gZUBk\WyuII\pZYJqdGm2eTDhd5NigS6LQ{WwQVAvPDJ7NUGg{txO	NWGzR\|duW0GQR1XS
OVCAR-4 cell	MX7Hdo94fGhiaX7obYJqfGmxbjDhd5NigQ>?		NVi3cZZoUW6qaXLpeIlwdiCxZjDoeY1idiCRVlPBVk01KGOnbHyg[5Jwf3SqIHnuJIEh[2WubDD2bYFjcWyrdImgZZN{[XlwSVO1NF0xNjN5NEOzJO69VQ>?	M4XNZnNCVkeHUh?=
NCI-H446 cell	NWP1c5U1T3Kxd4ToJIlvcGmkaYTpc44h[XO\|YYm=		NX31ZZNpUW6qaXLpeIlwdiCxZjDoeY1idiCQQ1mtTFQ1PiClZXzsJIdzd3e2aDDpckBiKGOnbHygeoli[mmuaYT5JIF{e2G7LlnDOVA:OC54Mke2JO69VQ>?	NYD4TZJRW0GQR1XS
NCI-H510A cell	NV3wTmp6T3Kxd4ToJIlvcGmkaYTpc44h[XO\|YYm=		MmX6TY5pcWKrdHnvckBw\iCqdX3hckBPS0lvSEWxNGEh[2WubDDndo94fGhiaX6gZUBk\WyuII\pZYJqdGm2eTDhd5NigS6LQ{WwQVE6NjN7N{Og{txO	MVvTRW5ITVJ?
PF-382 cell	NXTMeWxVT3Kxd4ToJIlvcGmkaYTpc44h[XO\|YYm=		NUDqZmhWUW6qaXLpeIlwdiCxZjDoeY1idiCSRj2zPFIh[2WubDDndo94fGhiaX6gZUBk\WyuII\pZYJqdGm2eTDhd5NigS6LQ{WwQVAvOTd4N{ig{txO	NVHHOo1iW0GQR1XS
NCI-H64 cell	MVnHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>?		MVnJcohq[mm2aX;uJI9nKGi3bXHuJG5EUS2KNkSgZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfU5KSzVyPUK5MlYzPTNizszN	M2e0XHNCVkeHUh?=
PSN1 cell	NE\KWmpIem:5dHigbY5pcWKrdHnvckBie3OjeR?=		NH7xcXJKdmirYnn0bY9vKG:oIHj1cYFvKFCVTkGgZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfU5KSzVyPUCuNFQ1PzRizszN	NIHqVmlUSU6JRWK=
QIMR-WIL cell	MY\Hdo94fGhiaX7obYJqfGmxbjDhd5NigQ>?		MmDLTY5pcWKrdHnvckBw\iCqdX3hckBSUU2ULWfJUEBk\WyuIHfyc5d1cCCrbjDhJINmdGxidnnhZoltcXS7IHHzd4F6NkmFNUC9NE44ODZ{OTFOwG0>	MVnTRW5ITVJ?
RL95-2 cell	MmTZS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl?		NX32[4hRUW6qaXLpeIlwdiCxZjDoeY1idiCUTEm1MVIh[2WubDDndo94fGhiaX6gZUBk\WyuII\pZYJqdGm2eTDhd5NigS6LQ{WwQVAvOTB\|ODFOwG0>	MYnTRW5ITVJ?
RCC10RGB cell	M3q3Wmdzd3e2aDDpcohq[mm2aX;uJIF{e2G7		NUXvXZBvUW6qaXLpeIlwdiCxZjDoeY1idiCUQ1OxNHJISiClZXzsJIdzd3e2aDDpckBiKGOnbHygeoli[mmuaYT5JIF{e2G7LlnDOVA:OC52OUGxJO69VQ>?	M3vvVHNCVkeHUh?=
RKO cell	MYXHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>?		M3rMZ2lvcGmkaYTpc44hd2ZiaIXtZY4hWkuRIHPlcIwh\3Kxd4ToJIlvKGFiY3XscEB3cWGkaXzpeJkh[XO\|YYmuTWM2OD1yLkWyPVY3KM7:TR?=	M3LPTHNCVkeHUh?=
NCI-SNU-16 cell	MXzHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>?		NXLqepFuUW6qaXLpeIlwdiCxZjDoeY1idiCQQ1mtV25WNTF4IHPlcIwh\3Kxd4ToJIlvKGFiY3XscEB3cWGkaXzpeJkh[XO\|YYmuTWM2OD16LkW2NVI5KM7:TR?=	MYDTRW5ITVJ?
RPMI-6666 cell	MkDlS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl?		NIDNSZlKdmirYnn0bY9vKG:oIHj1cYFvKFKSTVmtOlY3PiClZXzsJIdzd3e2aDDpckBiKGOnbHygeoli[mmuaYT5JIF{e2G7LlnDOVA:Py5{N{C2O{DPxE1?	MWXTRW5ITVJ?
NEC8 cell	MYLHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>?		NHrRcFNKdmirYnn0bY9vKG:oIHj1cYFvKE6HQ{igZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfU5KSzVyPUS0MlM{PiEQvF2=	MnfEV2FPT0WU
RS4-11 cell	M4jubWdzd3e2aDDpcohq[mm2aX;uJIF{e2G7		NEnEcGRKdmirYnn0bY9vKG:oIHj1cYFvKFKVND2xNUBk\WyuIHfyc5d1cCCrbjDhJINmdGxidnnhZoltcXS7IHHzd4F6NkmFNUC9O{43PTd6NzFOwG0>	MYjTRW5ITVJ?
RXF393 cell	MkTtS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl?		Ml\3TY5pcWKrdHnvckBw\iCqdX3hckBTYEZ\|OUOgZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfU5KSzVyPUCuNFI{PTdizszN	MmrJV2FPT0WU
Raji cell	MWrHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>?		NXzPR3U4UW6qaXLpeIlwdiCxZjDoeY1idiCUYXrpJINmdGxiZ4Lve5RpKGmwIHGgZ4VtdCC4aXHibYxqfHliYYPzZZkvUUN3ME2xN{44PDl5IN88US=>	MX;TRW5ITVJ?
NOS-1 cell	NGTyRY1Iem:5dHigbY5pcWKrdHnvckBie3OjeR?=		NEXpe3hKdmirYnn0bY9vKG:oIHj1cYFvKE6RUz2xJINmdGxiZ4Lve5RpKGmwIHGgZ4VtdCC4aXHibYxqfHliYYPzZZkvUUN3ME2wMlAxPjF{OTFOwG0>	MkDGV2FPT0WU
SBC-1 cell	M4nGd2dzd3e2aDDpcohq[mm2aX;uJIF{e2G7		MkfVTY5pcWKrdHnvckBw\iCqdX3hckBUSkNvMTDj[YxtKGe{b4f0bEBqdiCjIHPlcIwhfmmjYnnsbZR6KGG\|c3H5MmlEPTB;MT61O\|k5PCEQvF2=	M4LkNXNCVkeHUh?=
SF126 cell	Mn;PS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl?		NHjqW2lKdmirYnn0bY9vKG:oIHj1cYFvKFOIMUK2JINmdGxiZ4Lve5RpKGmwIHGgZ4VtdCC4aXHibYxqfHliYYPzZZkvUUN3ME2wMlM2PDFizszN	M2Cx[XNCVkeHUh?=
SF539 cell	M1HpPGdzd3e2aDDpcohq[mm2aX;uJIF{e2G7		MVjJcohq[mm2aX;uJI9nKGi3bXHuJHNHPTN7IHPlcIwh\3Kxd4ToJIlvKGFiY3XscEB3cWGkaXzpeJkh[XO\|YYmuTWM2OD1zMz64OVU4KM7:TR?=	MmTqV2FPT0WU
SH-4 cell	MVHHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>?		M37oU2lvcGmkaYTpc44hd2ZiaIXtZY4hW0hvNDDj[YxtKGe{b4f0bEBqdiCjIHPlcIwhfmmjYnnsbZR6KGG\|c3H5MmlEPTB;MD6xPFQyOyEQvF2=	MXTTRW5ITVJ?
OMC-1 cell	NUnDb\|lkT3Kxd4ToJIlvcGmkaYTpc44h[XO\|YYm=		MX;Jcohq[mm2aX;uJI9nKGi3bXHuJG9OSy1zIHPlcIwh\3Kxd4ToJIlvKGFiY3XscEB3cWGkaXzpeJkh[XO\|YYmuTWM2OD1{Nz6xOFIzKM7:TR?=	NUnSTmxkW0GQR1XS
SIG-M5 cell	M3TYZ2dzd3e2aDDpcohq[mm2aX;uJIF{e2G7		NIPoeYFKdmirYnn0bY9vKG:oIHj1cYFvKFOLRz3NOUBk\WyuIHfyc5d1cCCrbjDhJINmdGxidnnhZoltcXS7IHHzd4F6NkmFNUC9PU4xOjR7MzFOwG0>	MY\TRW5ITVJ?
SJSA-1 cell	NXrzUIdwT3Kxd4ToJIlvcGmkaYTpc44h[XO\|YYm=		M2fWbWlvcGmkaYTpc44hd2ZiaIXtZY4hW0qVQT2xJINmdGxiZ4Lve5RpKGmwIHGgZ4VtdCC4aXHibYxqfHliYYPzZZkvUUN3ME24MlczQDB3IN88US=>	MV3TRW5ITVJ?
SK-LMS-1 cell	M2OxVmdzd3e2aDDpcohq[mm2aX;uJIF{e2G7		MX\Jcohq[mm2aX;uJI9nKGi3bXHuJHNMNUyPUz2xJINmdGxiZ4Lve5RpKGmwIHGgZ4VtdCC4aXHibYxqfHliYYPzZZkvUUN3ME2zMlEyQDh4IN88US=>	M2jtTHNCVkeHUh?=
SK-NEP-1 cell	NWLSbmw2T3Kxd4ToJIlvcGmkaYTpc44h[XO\|YYm=		M1jRUmlvcGmkaYTpc44hd2ZiaIXtZY4hW0tvTlXQMVEh[2WubDDndo94fGhiaX6gZUBk\WyuII\pZYJqdGm2eTDhd5NigS6LQ{WwQVgvQDlzNUWg{txO	NUmwUm9rW0GQR1XS
SKM-1 cell	NEmyUXRIem:5dHigbY5pcWKrdHnvckBie3OjeR?=		MknUTY5pcWKrdHnvckBw\iCqdX3hckBUU01vMTDj[YxtKGe{b4f0bEBqdiCjIHPlcIwhfmmjYnnsbZR6KGG\|c3H5MmlEPTB;OT6wNVc{PCEQvF2=	NYq2OIFXW0GQR1XS
SK-PN-DW cell	MYrHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>?		NYfpPFh4UW6qaXLpeIlwdiCxZjDoeY1idiCVSz3QUk1FXyClZXzsJIdzd3e2aDDpckBiKGOnbHygeoli[mmuaYT5JIF{e2G7LlnDOVA:OzZwMUm0N{DPxE1?	NFKye2ZUSU6JRWK=
SK-UT-1 cell	NETpU29Iem:5dHigbY5pcWKrdHnvckBie3OjeR?=		MYDJcohq[mm2aX;uJI9nKGi3bXHuJHNMNVWWLUGgZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfU5KSzVyPUKuNVY3QTNizszN	NEjCRXRUSU6JRWK=
SNB75 cell	NFPJXVNIem:5dHigbY5pcWKrdHnvckBie3OjeR?=		NGfISItKdmirYnn0bY9vKG:oIHj1cYFvKFOQQke1JINmdGxiZ4Lve5RpKGmwIHGgZ4VtdCC4aXHibYxqfHliYYPzZZkvUUN3ME2wMlA1PDN3IN88US=>	MnfqV2FPT0WU
REH cell	NWrMZpM5T3Kxd4ToJIlvcGmkaYTpc44h[XO\|YYm=		MWfJcohq[mm2aX;uJI9nKGi3bXHuJHJGUCClZXzsJIdzd3e2aDDpckBiKGOnbHygeoli[mmuaYT5JIF{e2G7LlnDOVA:OjBwNkO1O{DPxE1?	NFjCVoZUSU6JRWK=
SNU-C2B cell	M3\5XGdzd3e2aDDpcohq[mm2aX;uJIF{e2G7		MkD6TY5pcWKrdHnvckBw\iCqdX3hckBUVlVvQ{LCJINmdGxiZ4Lve5RpKGmwIHGgZ4VtdCC4aXHibYxqfHliYYPzZZkvUUN3ME2xMlMxPTh7IN88US=>	M{HJdXNCVkeHUh?=
RPMI-8866 cell	MnXoS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl?		MmLjTY5pcWKrdHnvckBw\iCqdX3hckBTWE2LLUi4OlYh[2WubDDndo94fGhiaX6gZUBk\WyuII\pZYJqdGm2eTDhd5NigS6LQ{WwQVE4NjR2NUWg{txO	M13KbXNCVkeHUh?=
SW872 cell	NHjQ[2pIem:5dHigbY5pcWKrdHnvckBie3OjeR?=		NHv6d3FKdmirYnn0bY9vKG:oIHj1cYFvKFOZOEeyJINmdGxiZ4Lve5RpKGmwIHGgZ4VtdCC4aXHibYxqfHliYYPzZZkvUUN3ME2wMlA1OTZzIN88US=>	NICxOmlUSU6JRWK=
SW962 cell	MYnHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>?		NGi0[lVKdmirYnn0bY9vKG:oIHj1cYFvKFOZOU[yJINmdGxiZ4Lve5RpKGmwIHGgZ4VtdCC4aXHibYxqfHliYYPzZZkvUUN3ME2wMlEyOjl{IN88US=>	MULTRW5ITVJ?
SF268 cell	NFnzN3dIem:5dHigbY5pcWKrdHnvckBie3OjeR?=		NFq2V4ZKdmirYnn0bY9vKG:oIHj1cYFvKFOIMk[4JINmdGxiZ4Lve5RpKGmwIHGgZ4VtdCC4aXHibYxqfHliYYPzZZkvUUN3ME2wMlE4PDB2IN88US=>	M{C5[3NCVkeHUh?=
TE-1 cell	NGnSOHhIem:5dHigbY5pcWKrdHnvckBie3OjeR?=		MX\Jcohq[mm2aX;uJI9nKGi3bXHuJHRGNTFiY3XscEBoem:5dHigbY4h[SClZXzsJJZq[WKrbHn0fUBie3OjeT7JR\|UxRTBwMUC1OEDPxE1?	MoOzV2FPT0WU
8-MG-BA cell	NGX1dFBIem:5dHigbY5pcWKrdHnvckBie3OjeR?=		M3[3cWlvcGmkaYTpc44hd2ZiaIXtZY4hQC2PRz3CRUBk\WyuIHfyc5d1cCCrbjDhJINmdGxidnnhZoltcXS7IHHzd4F6NkmFNUC9NE4yPTR3ODFOwG0>	M1K5dHNCVkeHUh?=
A101D cell	NXL4W3NpT3Kxd4ToJIlvcGmkaYTpc44h[XO\|YYm=		Mn:zTY5pcWKrdHnvckBw\iCqdX3hckBCOTBzRDDj[YxtKGe{b4f0bEBqdiCjIHPlcIwhfmmjYnnsbZR6KGG\|c3H5MmlEPTB;MT6wN\|A1OyEQvF2=	M4HRNnNCVkeHUh?=
A253 cell	NGrC[FFIem:5dHigbY5pcWKrdHnvckBie3OjeR?=		NVrOdnVXUW6qaXLpeIlwdiCxZjDoeY1idiCDMkWzJINmdGxiZ4Lve5RpKGmwIHGgZ4VtdCC4aXHibYxqfHliYYPzZZkvUUN3ME2zMlc{OjR4IN88US=>	M1zmVHNCVkeHUh?=
A3-KAW cell	MkjJS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl?		Mn3qTY5pcWKrdHnvckBw\iCqdX3hckBCOy2NQWegZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfU5KSzVyPUCuPVg1PTJizszN	MomzV2FPT0WU
A4-Fuk cell	NHXyNFdIem:5dHigbY5pcWKrdHnvckBie3OjeR?=		M2TyUGlvcGmkaYTpc44hd2ZiaIXtZY4hSTRvRoXrJINmdGxiZ4Lve5RpKGmwIHGgZ4VtdCC4aXHibYxqfHliYYPzZZkvUUN3ME2zPE4yODB7IN88US=>	MkHHV2FPT0WU
A388 cell	NYXvfFBLT3Kxd4ToJIlvcGmkaYTpc44h[XO\|YYm=		NEW2SldKdmirYnn0bY9vKG:oIHj1cYFvKEF\|OEigZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfU5KSzVyPUCuNFUxQTVizszN	MnHHV2FPT0WU
ACN cell	M4OyNWdzd3e2aDDpcohq[mm2aX;uJIF{e2G7		NVPvPIJCUW6qaXLpeIlwdiCxZjDoeY1idiCDQ16gZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfU5KSzVyPUGuPFIzPTJizszN	NILG[mJUSU6JRWK=
A704 cell	NEnRc3RIem:5dHigbY5pcWKrdHnvckBie3OjeR?=		M3mwVGlvcGmkaYTpc44hd2ZiaIXtZY4hSTdyNDDj[YxtKGe{b4f0bEBqdiCjIHPlcIwhfmmjYnnsbZR6KGG\|c3H5MmlEPTB;MD6wNVQ6OSEQvF2=	NX\PfY1yW0GQR1XS
ALL-PO cell	NYHEdGhpT3Kxd4ToJIlvcGmkaYTpc44h[XO\|YYm=		NHTONFlKdmirYnn0bY9vKG:oIHj1cYFvKEGOTD3QU{Bk\WyuIHfyc5d1cCCrbjDhJINmdGxidnnhZoltcXS7IHHzd4F6NkmFNUC9NVAvPzl\|ODFOwG0>	NVvmXJhMW0GQR1XS
ARH-77 cell	MYLHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>?		NHjmRllKdmirYnn0bY9vKG:oIHj1cYFvKEGUSD23O{Bk\WyuIHfyc5d1cCCrbjDhJINmdGxidnnhZoltcXS7IHHzd4F6NkmFNUC9N{41PjlzNTFOwG0>	NUXOfVU6W0GQR1XS
SR cell	NEfQRnRIem:5dHigbY5pcWKrdHnvckBie3OjeR?=		NILwfG1KdmirYnn0bY9vKG:oIHj1cYFvKFOUIHPlcIwh\3Kxd4ToJIlvKGFiY3XscEB3cWGkaXzpeJkh[XO\|YYmuTWM2OD12LkS5PVU1KM7:TR?=	NV\vN2JkW0GQR1XS
BB65-RCC cell	NFq0cndIem:5dHigbY5pcWKrdHnvckBie3OjeR?=		M4\0SmlvcGmkaYTpc44hd2ZiaIXtZY4hSkJ4NT3SR2Mh[2WubDDndo94fGhiaX6gZUBk\WyuII\pZYJqdGm2eTDhd5NigS6LQ{WwQVAvODh{Mkeg{txO	NWXQeZQ1W0GQR1XS
BB49-HNC cell	NGm0bZNIem:5dHigbY5pcWKrdHnvckBie3OjeR?=		MlvmTY5pcWKrdHnvckBw\iCqdX3hckBDSjR7LVjOR{Bk\WyuIHfyc5d1cCCrbjDhJINmdGxidnnhZoltcXS7IHHzd4F6NkmFNUC9NE4{QDV7OTFOwG0>	NUH5N4dYW0GQR1XS
BC-1 cell	NUH2bG5zT3Kxd4ToJIlvcGmkaYTpc44h[XO\|YYm=		M4PLOWlvcGmkaYTpc44hd2ZiaIXtZY4hSkNvMTDj[YxtKGe{b4f0bEBqdiCjIHPlcIwhfmmjYnnsbZR6KGG\|c3H5MmlEPTB;MkiuOlUyKM7:TR?=	MXvTRW5ITVJ?
BC-3 cell	MWPHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>?		NGPORnJKdmirYnn0bY9vKG:oIHj1cYFvKEKFLUOgZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfU5KSzVyPUGyMlEyOzhizszN	NHm5PW9USU6JRWK=
BL-41 cell	M2\1VWdzd3e2aDDpcohq[mm2aX;uJIF{e2G7		M1XYWGlvcGmkaYTpc44hd2ZiaIXtZY4hSkxvNEGgZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfU5KSzVyPUCuNlkyOjNizszN	NVnDWHg{W0GQR1XS
BL-70 cell	Mm\iS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl?		NIr0dWFKdmirYnn0bY9vKG:oIHj1cYFvKEKOLUewJINmdGxiZ4Lve5RpKGmwIHGgZ4VtdCC4aXHibYxqfHliYYPzZZkvUUN3ME2wMlAxODByMEiyNVgh\|ryP	NITxVmJUSU6JRWK=
SW684 cell	NYC1NGVkT3Kxd4ToJIlvcGmkaYTpc44h[XO\|YYm=		M1vIXWlvcGmkaYTpc44hd2ZiaIXtZY4hW1d4OESgZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfU5KSzVyPUCuN\|Q6QCEQvF2=	NXTVO\|N6W0GQR1XS
BOKU cell	NIHKbnhIem:5dHigbY5pcWKrdHnvckBie3OjeR?=		NH\WVmJKdmirYnn0bY9vKG:oIHj1cYFvKEKRS2WgZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfU5KSzVyPUCuOFkyOzNizszN	MVrTRW5ITVJ?
SW954 cell	NI\yOGNIem:5dHigbY5pcWKrdHnvckBie3OjeR?=		MUjJcohq[mm2aX;uJI9nKGi3bXHuJHNYQTV2IHPlcIwh\3Kxd4ToJIlvKGFiY3XscEB3cWGkaXzpeJkh[XO\|YYmuTWM2OD1yLkCyPVI4KM7:TR?=	M4nYd3NCVkeHUh?=
C2BBe1 cell	MWfHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>?		NXfZOHdYUW6qaXLpeIlwdiCxZjDoeY1idiCFMlLC[VEh[2WubDDndo94fGhiaX6gZUBk\WyuII\pZYJqdGm2eTDhd5NigS6LQ{WwQVAvODh\|MEig{txO	Ml7qV2FPT0WU
BV-173 cell	M{LCOGdzd3e2aDDpcohq[mm2aX;uJIF{e2G7		MoO0TY5pcWKrdHnvckBw\iCqdX3hckBDXi1zN{OgZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfU5KSzVyPUCuNFAxODByMUC5JO69VQ>?	NFLReI5USU6JRWK=
Becker cell	MYHHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>?		MoGxTY5pcWKrdHnvckBw\iCqdX3hckBD\WOtZYKgZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfU5KSzVyPUCuNFMxODNizszN	MUfTRW5ITVJ?
SW982 cell	NYrsOlFwT3Kxd4ToJIlvcGmkaYTpc44h[XO\|YYm=		M4HrZ2lvcGmkaYTpc44hd2ZiaIXtZY4hW1d7OEKgZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfU5KSzVyPUCuNFEyOTVizszN	NH7GW2tUSU6JRWK=
697 cell	NEjwUI5Iem:5dHigbY5pcWKrdHnvckBie3OjeR?=		MYnJcohq[mm2aX;uJI9nKGi3bXHuJFY6PyClZXzsJIdzd3e2aDDpckBiKGOnbHygeoli[mmuaYT5JIF{e2G7LlnDOVA:OC5zOUm4O{DPxE1?	NWrvbGdRW0GQR1XS
TE-15 cell	NX:1fmxmT3Kxd4ToJIlvcGmkaYTpc44h[XO\|YYm=		M1T2OWlvcGmkaYTpc44hd2ZiaIXtZY4hXEVvMUWgZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfU5KSzVyPUCuNFA2QDlzIN88US=>	NUP2V3JVW0GQR1XS
TE-11 cell	MYXHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>?		MWfJcohq[mm2aX;uJI9nKGi3bXHuJHRGNTFzIHPlcIwh\3Kxd4ToJIlvKGFiY3XscEB3cWGkaXzpeJkh[XO\|YYmuTWM2OD1yLkC3PFU5KM7:TR?=	M3ryfHNCVkeHUh?=
TE-5 cell	MoT2S5Jwf3SqIHnubIljcXSrb36gZZN{[Xl?		NIrRcGtKdmirYnn0bY9vKG:oIHj1cYFvKFSHLUWgZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfU5KSzVyPUGuO\|kyOzlizszN	MUDTRW5ITVJ?
TE-6 cell	M3ztcWdzd3e2aDDpcohq[mm2aX;uJIF{e2G7		MlTiTY5pcWKrdHnvckBw\iCqdX3hckBVTS14IHPlcIwh\3Kxd4ToJIlvKGFiY3XscEB3cWGkaXzpeJkh[XO\|YYmuTWM2OD1zLkKxNlI3KM7:TR?=	MWTTRW5ITVJ?
TE-9 cell	NVjjTZA{T3Kxd4ToJIlvcGmkaYTpc44h[XO\|YYm=		M2fwZ2lvcGmkaYTpc44hd2ZiaIXtZY4hXEVvOTDj[YxtKGe{b4f0bEBqdiCjIHPlcIwhfmmjYnnsbZR6KGG\|c3H5MmlEPTB;MD64O\|U{OiEQvF2=	M2PkbXNCVkeHUh?=
TGBC24TKB cell	NF7GPXRIem:5dHigbY5pcWKrdHnvckBie3OjeR?=		NGHMeINKdmirYnn0bY9vKG:oIHj1cYFvKFSJQlOyOHRMSiClZXzsJIdzd3e2aDDpckBiKGOnbHygeoli[mmuaYT5JIF{e2G7LlnDOVA:OC5yNEe2NUDPxE1?	NV\ZW21vW0GQR1XS
TGW cell	MVHHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>?		MUPJcohq[mm2aX;uJI9nKGi3bXHuJHRIXyClZXzsJIdzd3e2aDDpckBiKGOnbHygeoli[mmuaYT5JIF{e2G7LlnDOVA:OTFwMkiyPEDPxE1?	MYHTRW5ITVJ?
TK10 cell	NEPvNYpIem:5dHigbY5pcWKrdHnvckBie3OjeR?=		MnfjTY5pcWKrdHnvckBw\iCqdX3hckBVUzFyIHPlcIwh\3Kxd4ToJIlvKGFiY3XscEB3cWGkaXzpeJkh[XO\|YYmuTWM2OD1yLkCxNVc1KM7:TR?=	M2G4OHNCVkeHUh?=
TGBC1TKB cell	MofWS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl?		MUnJcohq[mm2aX;uJI9nKGi3bXHuJHRISkNzVFvCJINmdGxiZ4Lve5RpKGmwIHGgZ4VtdCC4aXHibYxqfHliYYPzZZkvUUN3ME2wMlA3OTZ2IN88US=>	NYjuUop[W0GQR1XS
A498 cell	NYTsNWc4T3Kxd4ToJIlvcGmkaYTpc44h[XO\|YYm=		MmXyTY5pcWKrdHnvckBw\iCqdX3hckBCPDl6IHPlcIwh\3Kxd4ToJIlvKGFiY3XscEB3cWGkaXzpeJkh[XO\|YYmuTWM2OD1yLkC3Nlg1KM7:TR?=	NGrwNoRUSU6JRWK=
UACC-257 cell	MXXHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>?		MlzDTY5pcWKrdHnvckBw\iCqdX3hckBWSUOFLUK1O{Bk\WyuIHfyc5d1cCCrbjDhJINmdGxidnnhZoltcXS7IHHzd4F6NkmFNUC9NVIvQTF7ODFOwG0>	MVnTRW5ITVJ?
U-87-MG cell	NFvVOHhIem:5dHigbY5pcWKrdHnvckBie3OjeR?=		Ml;wTY5pcWKrdHnvckBw\iCqdX3hckBWNTh5LV3HJINmdGxiZ4Lve5RpKGmwIHGgZ4VtdCC4aXHibYxqfHliYYPzZZkvUUN3ME2zNE44PjZizszN	MlL1V2FPT0WU
BB30-HNC cell	MWnHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>?		MoDVTY5pcWKrdHnvckBw\iCqdX3hckBDSjNyLVjOR{Bk\WyuIHfyc5d1cCCrbjDhJINmdGxidnnhZoltcXS7IHHzd4F6NkmFNUC9NE4xPTR\|NzFOwG0>	MnTSV2FPT0WU
no-10 cell	NX[3WXlqT3Kxd4ToJIlvcGmkaYTpc44h[XO\|YYm=		NUnSdHBtUW6qaXLpeIlwdiCxZjDoeY1idiCwbz2xNEBk\WyuIHfyc5d1cCCrbjDhJINmdGxidnnhZoltcXS7IHHzd4F6NkmFNUC9NE4{OTl\|MTFOwG0>	MXjTRW5ITVJ?
CAS-1 cell	NEDzRnpIem:5dHigbY5pcWKrdHnvckBie3OjeR?=		M{LG[GlvcGmkaYTpc44hd2ZiaIXtZY4hS0GVLUGgZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfU5KSzVyPUGuOFA6QTJizszN	M17rSHNCVkeHUh?=
CGTH-W-1 cell	NVu2T5F1T3Kxd4ToJIlvcGmkaYTpc44h[XO\|YYm=		Mo\NTY5pcWKrdHnvckBw\iCqdX3hckBET1SKLWetNUBk\WyuIHfyc5d1cCCrbjDhJINmdGxidnnhZoltcXS7IHHzd4F6NkmFNUC9NE4xOzV2ODFOwG0>	MmfkV2FPT0WU
TE-10 cell	NWnjdotRT3Kxd4ToJIlvcGmkaYTpc44h[XO\|YYm=		M3vJbGlvcGmkaYTpc44hd2ZiaIXtZY4hXEVvMUCgZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfU5KSzVyPUCuNFY{PTdizszN	MnvuV2FPT0WU
COLO-684 cell	NGW0fZBIem:5dHigbY5pcWKrdHnvckBie3OjeR?=		NHLGNpNKdmirYnn0bY9vKG:oIHj1cYFvKEORTF:tOlg1KGOnbHyg[5Jwf3SqIHnuJIEh[2WubDD2bYFjcWyrdImgZZN{[XlwSVO1NF01Pi5{MkW4JO69VQ>?	NGHIXJNUSU6JRWK=
TE-12 cell	NFfPUFJIem:5dHigbY5pcWKrdHnvckBie3OjeR?=		M2DLbGlvcGmkaYTpc44hd2ZiaIXtZY4hXEVvMUKgZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfU5KSzVyPUCuNFE5PjFizszN	NF;KXWtUSU6JRWK=
COR-L279 cell	M4Du[Wdzd3e2aDDpcohq[mm2aX;uJIF{e2G7		NFzmTGhKdmirYnn0bY9vKG:oIHj1cYFvKEORUj3MNlc6KGOnbHyg[5Jwf3SqIHnuJIEh[2WubDD2bYFjcWyrdImgZZN{[XlwSVO1NF01OC5{OEWyJO69VQ>?	NIHvfoZUSU6JRWK=
TE-8 cell	M4f1W2dzd3e2aDDpcohq[mm2aX;uJIF{e2G7		NV3PNmM3UW6qaXLpeIlwdiCxZjDoeY1idiCWRT24JINmdGxiZ4Lve5RpKGmwIHGgZ4VtdCC4aXHibYxqfHliYYPzZZkvUUN3ME2wMlAyPTd4IN88US=>	NV\rbm95W0GQR1XS
CP66-MEL cell	MVHHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>?		NULjRZRTUW6qaXLpeIlwdiCxZjDoeY1idiCFUE[2MW1GVCClZXzsJIdzd3e2aDDpckBiKGOnbHygeoli[mmuaYT5JIF{e2G7LlnDOVA:OC5zOUWzNUDPxE1?	MmO2V2FPT0WU
CTV-1 cell	MV7Hdo94fGhiaX7obYJqfGmxbjDhd5NigQ>?		M2POT2lvcGmkaYTpc44hd2ZiaIXtZY4hS1SYLUGgZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfU5KSzVyPUCuNFAxODRyM{[g{txO	M4DkcnNCVkeHUh?=
VA-ES-BJ cell	M{jHNWdzd3e2aDDpcohq[mm2aX;uJIF{e2G7		NILiUXRKdmirYnn0bY9vKG:oIHj1cYFvKF[DLVXTMWJLKGOnbHyg[5Jwf3SqIHnuJIEh[2WubDD2bYFjcWyrdImgZZN{[XlwSVO1NF0xNjB\|OUCyJO69VQ>?	NEfPWJFUSU6JRWK=
D-263MG cell	M2HaRmdzd3e2aDDpcohq[mm2aX;uJIF{e2G7		NXmwXIZqUW6qaXLpeIlwdiCxZjDoeY1idiCGLUK2N21IKGOnbHyg[5Jwf3SqIHnuJIEh[2WubDD2bYFjcWyrdImgZZN{[XlwSVO1NF0xNjN4MkK0JO69VQ>?	MWPTRW5ITVJ?
D-336MG cell	NIP1NFlIem:5dHigbY5pcWKrdHnvckBie3OjeR?=		MX7Jcohq[mm2aX;uJI9nKGi3bXHuJGQuOzN4TVegZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfU5KSzVyPUCuNFA3Ojl6IN88US=>	NYP6XpQzW0GQR1XS
D-502MG cell	M4LCcmdzd3e2aDDpcohq[mm2aX;uJIF{e2G7		M3nBdGlvcGmkaYTpc44hd2ZiaIXtZY4hTC13MELNS{Bk\WyuIHfyc5d1cCCrbjDhJINmdGxidnnhZoltcXS7IHHzd4F6NkmFNUC9NU4zOzN5NjFOwG0>	M2jvVnNCVkeHUh?=
DJM-1 cell	MkfVS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl?		MVnJcohq[mm2aX;uJI9nKGi3bXHuJGRLVS1zIHPlcIwh\3Kxd4ToJIlvKGFiY3XscEB3cWGkaXzpeJkh[XO\|YYmuTWM2OD14LkS4OVU5KM7:TR?=	MmjNV2FPT0WU
no-11 cell	Mn3SS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl?		NWjiR5pkUW6qaXLpeIlwdiCxZjDoeY1idiCwbz2xNUBk\WyuIHfyc5d1cCCrbjDhJINmdGxidnnhZoltcXS7IHHzd4F6NkmFNUC9NE42ODJ{ODFOwG0>	MlmyV2FPT0WU
DMS-153 cell	MmPjS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl?		NXmwfVg1UW6qaXLpeIlwdiCxZjDoeY1idiCGTWOtNVU{KGOnbHyg[5Jwf3SqIHnuJIEh[2WubDD2bYFjcWyrdImgZZN{[XlwSVO1NF0yPC5yMEK4JO69VQ>?	MYTTRW5ITVJ?
DSH1 cell	NYPK[4M2T3Kxd4ToJIlvcGmkaYTpc44h[XO\|YYm=		MnP0TY5pcWKrdHnvckBw\iCqdX3hckBFW0hzIHPlcIwh\3Kxd4ToJIlvKGFiY3XscEB3cWGkaXzpeJkh[XO\|YYmuTWM2OD1yLkK0NFAyKM7:TR?=	MWfTRW5ITVJ?
DU-4475 cell	MYHHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>?		NWT2UIVkUW6qaXLpeIlwdiCxZjDoeY1idiCGVT20OFc2KGOnbHyg[5Jwf3SqIHnuJIEh[2WubDD2bYFjcWyrdImgZZN{[XlwSVO1NF05NjJzNkWyJO69VQ>?	MoLqV2FPT0WU
EB-3 cell	NVLWU4dKT3Kxd4ToJIlvcGmkaYTpc44h[XO\|YYm=		MULJcohq[mm2aX;uJI9nKGi3bXHuJGVDNTNiY3XscEBoem:5dHigbY4h[SClZXzsJJZq[WKrbHn0fUBie3OjeT7JR\|UxRTN2LkOxNVgh\|ryP	MULTRW5ITVJ?
EHEB cell	MlrBS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl?		MXfJcohq[mm2aX;uJI9nKGi3bXHuJGVJTUJiY3XscEBoem:5dHigbY4h[SClZXzsJJZq[WKrbHn0fUBie3OjeT7JR\|UxRTFyLkC2OVYh\|ryP	Mni1V2FPT0WU
COLO-829 cell	M2DCeWdzd3e2aDDpcohq[mm2aX;uJIF{e2G7		MX\Jcohq[mm2aX;uJI9nKGi3bXHuJGNQVE9vOEK5JINmdGxiZ4Lve5RpKGmwIHGgZ4VtdCC4aXHibYxqfHliYYPzZZkvUUN3ME2wMlEzOjF\|IN88US=>	MVnTRW5ITVJ?
CP67-MEL cell	NHv4SGFIem:5dHigbY5pcWKrdHnvckBie3OjeR?=		NGD1UmxKdmirYnn0bY9vKG:oIHj1cYFvKEOSNketUWVNKGOnbHyg[5Jwf3SqIHnuJIEh[2WubDD2bYFjcWyrdImgZZN{[XlwSVO1NF0xNjJyNEi4JO69VQ>?	NXPaSXpkW0GQR1XS
ES8 cell	MVXHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>?		NUPTVGRXUW6qaXLpeIlwdiCxZjDoeY1idiCHU{igZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfU5KSzVyPUOyMlEzPTJizszN	MkLDV2FPT0WU
EVSA-T cell	NFv5dJBIem:5dHigbY5pcWKrdHnvckBie3OjeR?=		MVrJcohq[mm2aX;uJI9nKGi3bXHuJGVXW0FvVDDj[YxtKGe{b4f0bEBqdiCjIHPlcIwhfmmjYnnsbZR6KGG\|c3H5MmlEPTB;OT6yO\|c6OyEQvF2=	NHvL[pFUSU6JRWK=
ES4 cell	MXLHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>?		NVfSfWdZUW6qaXLpeIlwdiCxZjDoeY1idiCHU{SgZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfU5KSzVyPUGuNFUyPDVizszN	MVHTRW5ITVJ?
ETK-1 cell	NVGyTZVTT3Kxd4ToJIlvcGmkaYTpc44h[XO\|YYm=		MknETY5pcWKrdHnvckBw\iCqdX3hckBGXEtvMTDj[YxtKGe{b4f0bEBqdiCjIHPlcIwhfmmjYnnsbZR6KGG\|c3H5MmlEPTB;MD6wNlg{OiEQvF2=	NFHxcVJUSU6JRWK=
ES6 cell	NGDHW2dIem:5dHigbY5pcWKrdHnvckBie3OjeR?=		MoTnTY5pcWKrdHnvckBw\iCqdX3hckBGWzZiY3XscEBoem:5dHigbY4h[SClZXzsJJZq[WKrbHn0fUBie3OjeT7JR\|UxRTBwMEOxPVMh\|ryP	NXnPbZFsW0GQR1XS
EW-24 cell	Ml7TS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl?		M2rYUWlvcGmkaYTpc44hd2ZiaIXtZY4hTVdvMkSgZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfU5KSzVyPUCuO\|gyPjVizszN	M4LtcXNCVkeHUh?=
EoL-1-cell cell	NITr[2VIem:5dHigbY5pcWKrdHnvckBie3OjeR?=		NXyzVI5GUW6qaXLpeIlwdiCxZjDoeY1idiCHb1ytNU1k\WyuIHPlcIwh\3Kxd4ToJIlvKGFiY3XscEB3cWGkaXzpeJkh[XO\|YYmuTWM2OD1yLkCwNFAyOzB7IN88US=>	MnnrV2FPT0WU
Calu-6 cell	MWXHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>?		M2LubWlvcGmkaYTpc44hd2ZiaIXtZY4hS2GudT22JINmdGxiZ4Lve5RpKGmwIHGgZ4VtdCC4aXHibYxqfHliYYPzZZkvUUN3ME2zMlA2PzRzIN88US=>	NH;4V4dUSU6JRWK=
GAK cell	MVvHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>?		M1\XUmlvcGmkaYTpc44hd2ZiaIXtZY4hT0GNIHPlcIwh\3Kxd4ToJIlvKGFiY3XscEB3cWGkaXzpeJkh[XO\|YYmuTWM2OD1\|MT6yOlg3KM7:TR?=	NEj1N\|dUSU6JRWK=
D-247MG cell	NUL6NWZGT3Kxd4ToJIlvcGmkaYTpc44h[XO\|YYm=		M1HDd2lvcGmkaYTpc44hd2ZiaIXtZY4hTC1{NEfNS{Bk\WyuIHfyc5d1cCCrbjDhJINmdGxidnnhZoltcXS7IHHzd4F6NkmFNUC9Ok4yOjVzOTFOwG0>	MVvTRW5ITVJ?
GB-1 cell	Mn;CS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl?		MYnJcohq[mm2aX;uJI9nKGi3bXHuJGdDNTFiY3XscEBoem:5dHigbY4h[SClZXzsJJZq[WKrbHn0fUBie3OjeT7JR\|UxRTBwMEKxOVch\|ryP	NHTHZ4lUSU6JRWK=
GI-ME-N cell	MXTHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>?		NVv1VZJZUW6qaXLpeIlwdiCxZjDoeY1idiCJST3NSU1PKGOnbHyg[5Jwf3SqIHnuJIEh[2WubDD2bYFjcWyrdImgZZN{[XlwSVO1NF0xNjB4MUG4JO69VQ>?	NWDES4tQW0GQR1XS
GCIY cell	MUHHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>?		M3r0R2lvcGmkaYTpc44hd2ZiaIXtZY4hT0OLWTDj[YxtKGe{b4f0bEBqdiCjIHPlcIwhfmmjYnnsbZR6KGG\|c3H5MmlEPTB;MD6wPVY2PiEQvF2=	MVHTRW5ITVJ?
GT3TKB cell	MV;Hdo94fGhiaX7obYJqfGmxbjDhd5NigQ>?		MULJcohq[mm2aX;uJI9nKGi3bXHuJGdVO1SNQjDj[YxtKGe{b4f0bEBqdiCjIHPlcIwhfmmjYnnsbZR6KGG\|c3H5MmlEPTB;OT6zOVU1PiEQvF2=	M2jGSXNCVkeHUh?=
HC-1 cell	NXz6Z\|JoT3Kxd4ToJIlvcGmkaYTpc44h[XO\|YYm=		Mk\ZTY5pcWKrdHnvckBw\iCqdX3hckBJSy1zIHPlcIwh\3Kxd4ToJIlvKGFiY3XscEB3cWGkaXzpeJkh[XO\|YYmuTWM2OD1{ND61OVUyKM7:TR?=	M1rkSXNCVkeHUh?=
HAL-01 cell	M1HSZmdzd3e2aDDpcohq[mm2aX;uJIF{e2G7		NFTUPIxKdmirYnn0bY9vKG:oIHj1cYFvKEiDTD2wNUBk\WyuIHfyc5d1cCCrbjDhJINmdGxidnnhZoltcXS7IHHzd4F6NkmFNUC9NVkvPzV2MzFOwG0>	NF3SbmVUSU6JRWK=
HCC1187 cell	MVHHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>?		NV\wXYtoUW6qaXLpeIlwdiCxZjDoeY1idiCKQ1OxNVg4KGOnbHyg[5Jwf3SqIHnuJIEh[2WubDD2bYFjcWyrdImgZZN{[XlwSVO1NF0{PS56MEWyJO69VQ>?	MlvyV2FPT0WU
DEL cell	NWH6O41PT3Kxd4ToJIlvcGmkaYTpc44h[XO\|YYm=		MUDJcohq[mm2aX;uJI9nKGi3bXHuJGRGVCClZXzsJIdzd3e2aDDpckBiKGOnbHygeoli[mmuaYT5JIF{e2G7LlnDOVA:PDFwOUC4OkDPxE1?	M3jXe3NCVkeHUh?=
HCC1599 cell	MUfHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>?		NWTKZ2F7UW6qaXLpeIlwdiCxZjDoeY1idiCKQ1OxOVk6KGOnbHyg[5Jwf3SqIHnuJIEh[2WubDD2bYFjcWyrdImgZZN{[XlwSVO1NF0{Oi5\|M{K1JO69VQ>?	NFX5S\|dUSU6JRWK=
DOHH-2 cell	NUTrPZI6T3Kxd4ToJIlvcGmkaYTpc44h[XO\|YYm=		M4HFcmlvcGmkaYTpc44hd2ZiaIXtZY4hTE:KSD2yJINmdGxiZ4Lve5RpKGmwIHGgZ4VtdCC4aXHibYxqfHliYYPzZZkvUUN3ME2wMlAyPzF7IN88US=>	M4SzPXNCVkeHUh?=
HCC2157 cell	NWfrbFdDT3Kxd4ToJIlvcGmkaYTpc44h[XO\|YYm=		NYC5bJF5UW6qaXLpeIlwdiCxZjDoeY1idiCKQ1OyNVU4KGOnbHyg[5Jwf3SqIHnuJIEh[2WubDD2bYFjcWyrdImgZZN{[XlwSVO1NF0{Py57OUS2JO69VQ>?	NX3Bc41TW0GQR1XS
HCE-4 cell	NYjvc29VT3Kxd4ToJIlvcGmkaYTpc44h[XO\|YYm=		NX3zbY1tUW6qaXLpeIlwdiCxZjDoeY1idiCKQ1WtOEBk\WyuIHfyc5d1cCCrbjDhJINmdGxidnnhZoltcXS7IHHzd4F6NkmFNUC9NE4zPjR\|OTFOwG0>	MWjTRW5ITVJ?
HCE-T cell	NFHINpZIem:5dHigbY5pcWKrdHnvckBie3OjeR?=		NILEOJNKdmirYnn0bY9vKG:oIHj1cYFvKEiFRT3UJINmdGxiZ4Lve5RpKGmwIHGgZ4VtdCC4aXHibYxqfHliYYPzZZkvUUN3ME2xMlU3PzF2IN88US=>	NHf6fW1USU6JRWK=
HEL cell	MV;Hdo94fGhiaX7obYJqfGmxbjDhd5NigQ>?		Mn3iTY5pcWKrdHnvckBw\iCqdX3hckBJTUxiY3XscEBoem:5dHigbY4h[SClZXzsJJZq[WKrbHn0fUBie3OjeT7JR\|UxRTFyLkS3O\|Yh\|ryP	NH6xO\|dUSU6JRWK=
EM-2 cell	MVjHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>?		NIXSRYVKdmirYnn0bY9vKG:oIHj1cYFvKEWPLUKgZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfU5KSzVyPUCuNFAxODBzMEe4JO69VQ>?	NVfEco46W0GQR1XS
HT-144 cell	NUH2R2tmT3Kxd4ToJIlvcGmkaYTpc44h[XO\|YYm=		NVrud2V4UW6qaXLpeIlwdiCxZjDoeY1idiCKVD2xOFQh[2WubDDndo94fGhiaX6gZUBk\WyuII\pZYJqdGm2eTDhd5NigS6LQ{WwQVAvPTN4MEmg{txO	MmfqV2FPT0WU
EW-16 cell	NGTHSFNIem:5dHigbY5pcWKrdHnvckBie3OjeR?=		M3X3NGlvcGmkaYTpc44hd2ZiaIXtZY4hTVdvMU[gZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfU5KSzVyPUCuO\|YyPzhizszN	NILKS25USU6JRWK=
IA-LM cell	MV7Hdo94fGhiaX7obYJqfGmxbjDhd5NigQ>?		NWK3VIE2UW6qaXLpeIlwdiCxZjDoeY1idiCLQT3MUUBk\WyuIHfyc5d1cCCrbjDhJINmdGxidnnhZoltcXS7IHHzd4F6NkmFNUC9NVIvPDR2NTFOwG0>	Mn[4V2FPT0WU
IST-MEL1 cell	NX\xNJhwT3Kxd4ToJIlvcGmkaYTpc44h[XO\|YYm=		NH[zbotKdmirYnn0bY9vKG:oIHj1cYFvKEmVVD3NSWwyKGOnbHyg[5Jwf3SqIHnuJIEh[2WubDD2bYFjcWyrdImgZZN{[XlwSVO1NF0xNjF\|NEWg{txO	Mnu3V2FPT0WU
IST-MES1 cell	NWDkSYF6T3Kxd4ToJIlvcGmkaYTpc44h[XO\|YYm=		M1PEUGlvcGmkaYTpc44hd2ZiaIXtZY4hUVOWLV3FV\|Eh[2WubDDndo94fGhiaX6gZUBk\WyuII\pZYJqdGm2eTDhd5NigS6LQ{WwQVAvODh3NUKg{txO	NXXvXVJXW0GQR1XS
GI-1 cell	MV;Hdo94fGhiaX7obYJqfGmxbjDhd5NigQ>?		MkDBTY5pcWKrdHnvckBw\iCqdX3hckBIUS1zIHPlcIwh\3Kxd4ToJIlvKGFiY3XscEB3cWGkaXzpeJkh[XO\|YYmuTWM2OD1zLkO2NlIh\|ryP	M1HKe3NCVkeHUh?=
IST-SL2 cell	M3jydmdzd3e2aDDpcohq[mm2aX;uJIF{e2G7		MXPJcohq[mm2aX;uJI9nKGi3bXHuJGlUXC2VTEKgZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfU5KSzVyPUCuOVA{ODJizszN	M2P1[3NCVkeHUh?=
JVM-2 cell	M1fFVGdzd3e2aDDpcohq[mm2aX;uJIF{e2G7		NYC5V2dRUW6qaXLpeIlwdiCxZjDoeY1idiCMVl2tNkBk\WyuIHfyc5d1cCCrbjDhJINmdGxidnnhZoltcXS7IHHzd4F6NkmFNUC9Nk4{PjJ6NDFOwG0>	MXzTRW5ITVJ?
JVM-3 cell	M1XtdWdzd3e2aDDpcohq[mm2aX;uJIF{e2G7		MVLJcohq[mm2aX;uJI9nKGi3bXHuJGpXVS1\|IHPlcIwh\3Kxd4ToJIlvKGFiY3XscEB3cWGkaXzpeJkh[XO\|YYmuTWM2OD1\|Nz6yN\|M5KM7:TR?=	MUnTRW5ITVJ?
KALS-1 cell	NWq4T4tKT3Kxd4ToJIlvcGmkaYTpc44h[XO\|YYm=		MnLXTY5pcWKrdHnvckBw\iCqdX3hckBMSUyVLUGgZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfU5KSzVyPUCuNFk1QSEQvF2=	M1LONXNCVkeHUh?=
KARPAS-422 cell	NFS3emRIem:5dHigbY5pcWKrdHnvckBie3OjeR?=		MmjmTY5pcWKrdHnvckBw\iCqdX3hckBMSVKSQWOtOFIzKGOnbHyg[5Jwf3SqIHnuJIEh[2WubDD2bYFjcWyrdImgZZN{[XlwSVO1NF0xNjN\|OUm3JO69VQ>?	NUC4c21qW0GQR1XS
JiyoyeP-2003 cell	NUnUU5NiT3Kxd4ToJIlvcGmkaYTpc44h[XO\|YYm=		Mn3ITY5pcWKrdHnvckBw\iCqdX3hckBLcXmxeXXQMVIxODNiY3XscEBoem:5dHigbY4h[SClZXzsJJZq[WKrbHn0fUBie3OjeT7JR\|UxRTFwN{O0OlYh\|ryP	NIXsdlNUSU6JRWK=
KARPAS-45 cell	NVvIbXRDT3Kxd4ToJIlvcGmkaYTpc44h[XO\|YYm=		MYHJcohq[mm2aX;uJI9nKGi3bXHuJGtCWlCDUz20OUBk\WyuIHfyc5d1cCCrbjDhJINmdGxidnnhZoltcXS7IHHzd4F6NkmFNUC9O{42OTZ5MTFOwG0>	NVuxW416W0GQR1XS
KGN cell	NH3Re3BIem:5dHigbY5pcWKrdHnvckBie3OjeR?=		MVjJcohq[mm2aX;uJI9nKGi3bXHuJGtIViClZXzsJIdzd3e2aDDpckBiKGOnbHygeoli[mmuaYT5JIF{e2G7LlnDOVA:OC5yMUm0NkDPxE1?	NHvme2xUSU6JRWK=
KLE cell	MUfHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>?		MljJTY5pcWKrdHnvckBw\iCqdX3hckBMVEViY3XscEBoem:5dHigbY4h[SClZXzsJJZq[WKrbHn0fUBie3OjeT7JR\|UxRTBwMUGzNVch\|ryP	MVjTRW5ITVJ?
KNS-42 cell	NXPH[oxFT3Kxd4ToJIlvcGmkaYTpc44h[XO\|YYm=		NH;HRZlKdmirYnn0bY9vKG:oIHj1cYFvKEuQUz20NkBk\WyuIHfyc5d1cCCrbjDhJINmdGxidnnhZoltcXS7IHHzd4F6NkmFNUC9NU4zPDRzMjFOwG0>	NVXmRWRRW0GQR1XS
KNS-81-FD cell	NGDkPVZIem:5dHigbY5pcWKrdHnvckBie3OjeR?=		NVnleXFWUW6qaXLpeIlwdiCxZjDoeY1idiCNTmOtPFEuTkRiY3XscEBoem:5dHigbY4h[SClZXzsJJZq[WKrbHn0fUBie3OjeT7JR\|UxRTJ\|LkG0OkDPxE1?	MW\TRW5ITVJ?
KP-N-YS cell	M1\CZmdzd3e2aDDpcohq[mm2aX;uJIF{e2G7		NWHSeJk{UW6qaXLpeIlwdiCxZjDoeY1idiCNUD3OMXlUKGOnbHyg[5Jwf3SqIHnuJIEh[2WubDD2bYFjcWyrdImgZZN{[XlwSVO1NF0yOi57MkizJO69VQ>?	M3zsSXNCVkeHUh?=
HOP-62 cell	NGP3N2dIem:5dHigbY5pcWKrdHnvckBie3OjeR?=		NITQUotKdmirYnn0bY9vKG:oIHj1cYFvKEiRUD22NkBk\WyuIHfyc5d1cCCrbjDhJINmdGxidnnhZoltcXS7IHHzd4F6NkmFNUC9NE4xOTh\|NDFOwG0>	M{TFd3NCVkeHUh?=
KURAMOCHI cell	MXHHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>?		NF\5cYJKdmirYnn0bY9vKG:oIHj1cYFvKEuXUlHNU2NJUSClZXzsJIdzd3e2aDDpckBiKGOnbHygeoli[mmuaYT5JIF{e2G7LlnDOVA:OC5yM{S4O{DPxE1?	NF3OZXZUSU6JRWK=
HUTU-80 cell	M13EXGdzd3e2aDDpcohq[mm2aX;uJIF{e2G7		MoTaTY5pcWKrdHnvckBw\iCqdX3hckBJXVSXLUiwJINmdGxiZ4Lve5RpKGmwIHGgZ4VtdCC4aXHibYxqfHliYYPzZZkvUUN3ME2wMlMyPDJizszN	NGfSWZBUSU6JRWK=
LAMA-84 cell	NHrLPJlIem:5dHigbY5pcWKrdHnvckBie3OjeR?=		M3\FdWlvcGmkaYTpc44hd2ZiaIXtZY4hVEGPQT24OEBk\WyuIHfyc5d1cCCrbjDhJINmdGxidnnhZoltcXS7IHHzd4F6NkmFNUC9NE4xODByMEOyNFch\|ryP	MnWxV2FPT0WU
LB1047-RCC cell	NXP4Z\|Z[T3Kxd4ToJIlvcGmkaYTpc44h[XO\|YYm=		M4ftb2lvcGmkaYTpc44hd2ZiaIXtZY4hVEJzMES3MXJESyClZXzsJIdzd3e2aDDpckBiKGOnbHygeoli[mmuaYT5JIF{e2G7LlnDOVA:OC5yMEm4PFch\|ryP	M1vVSHNCVkeHUh?=
LB2518-MEL cell	M{HlSmdzd3e2aDDpcohq[mm2aX;uJIF{e2G7		NI\FdFJKdmirYnn0bY9vKG:oIHj1cYFvKEyEMkWxPE1OTUxiY3XscEBoem:5dHigbY4h[SClZXzsJJZq[WKrbHn0fUBie3OjeT7JR\|UxRTBwMUSxOlIh\|ryP	MoLKV2FPT0WU
LB373-MEL-D cell	Mn[2S5Jwf3SqIHnubIljcXSrb36gZZN{[Xl?		M3zKV2lvcGmkaYTpc44hd2ZiaIXtZY4hVEJ\|N{OtUWVNNURiY3XscEBoem:5dHigbY4h[SClZXzsJJZq[WKrbHn0fUBie3OjeT7JR\|UxRTBwOEK1NFgh\|ryP	NX\xVWY2W0GQR1XS
LB771-HNC cell	MlTmS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl?		MXjJcohq[mm2aX;uJI9nKGi3bXHuJGxDPzdzLVjOR{Bk\WyuIHfyc5d1cCCrbjDhJINmdGxidnnhZoltcXS7IHHzd4F6NkmFNUC9Nk42PzV3MTFOwG0>	NELnTJdUSU6JRWK=
LB996-RCC cell	NGfCZoVIem:5dHigbY5pcWKrdHnvckBie3OjeR?=		M1\UeGlvcGmkaYTpc44hd2ZiaIXtZY4hVEJ7OU[tVmNEKGOnbHyg[5Jwf3SqIHnuJIEh[2WubDD2bYFjcWyrdImgZZN{[XlwSVO1NF0xNjByOUmxNkDPxE1?	M4ntZnNCVkeHUh?=
LC-2-ad cell	MX7Hdo94fGhiaX7obYJqfGmxbjDhd5NigQ>?		NInnN4JKdmirYnn0bY9vKG:oIHj1cYFvKEyFLUKtZYQh[2WubDDndo94fGhiaX6gZUBk\WyuII\pZYJqdGm2eTDhd5NigS6LQ{WwQVAvODJ3OE[g{txO	NVHpfnRmW0GQR1XS
J-RT3-T3-5 cell	NH\USFdIem:5dHigbY5pcWKrdHnvckBie3OjeR?=		MlrFTY5pcWKrdHnvckBw\iCqdX3hckBLNVKWMz3UN{02KGOnbHyg[5Jwf3SqIHnuJIEh[2WubDD2bYFjcWyrdImgZZN{[XlwSVO1NF05Njl4NUK5JO69VQ>?	NEDqWYtUSU6JRWK=
LP-1 cell	M4rjcWdzd3e2aDDpcohq[mm2aX;uJIF{e2G7		NUfDcokzUW6qaXLpeIlwdiCxZjDoeY1idiCOUD2xJINmdGxiZ4Lve5RpKGmwIHGgZ4VtdCC4aXHibYxqfHliYYPzZZkvUUN3ME23MlU1Pzh{IN88US=>	NXq3VY5JW0GQR1XS
K-562 cell	NV7hU5o2T3Kxd4ToJIlvcGmkaYTpc44h[XO\|YYm=		MWDJcohq[mm2aX;uJI9nKGi3bXHuJGsuPTZ{IHPlcIwh\3Kxd4ToJIlvKGFiY3XscEB3cWGkaXzpeJkh[XO\|YYmuTWM2OD1yLkCwNFAxODJ4NU[g{txO	NIfqR\|hUSU6JRWK=
LS-123 cell	Ml3JS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl?		NVrP[YdOUW6qaXLpeIlwdiCxZjDoeY1idiCOUz2xNlMh[2WubDDndo94fGhiaX6gZUBk\WyuII\pZYJqdGm2eTDhd5NigS6LQ{WwQVAvOTRyNkSg{txO	M4K1NXNCVkeHUh?=
K5 cell	MWTHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>?		MkDITY5pcWKrdHnvckBw\iCqdX3hckBMPSClZXzsJIdzd3e2aDDpckBiKGOnbHygeoli[mmuaYT5JIF{e2G7LlnDOVA:OC5zNkS4PUDPxE1?	MXzTRW5ITVJ?
LS-411N cell	M13vd2dzd3e2aDDpcohq[mm2aX;uJIF{e2G7		NGfpO2FKdmirYnn0bY9vKG:oIHj1cYFvKEyVLUSxNW4h[2WubDDndo94fGhiaX6gZUBk\WyuII\pZYJqdGm2eTDhd5NigS6LQ{WwQVQ5NjR5NEig{txO	MXjTRW5ITVJ?
KG-1 cell	M1\nc2dzd3e2aDDpcohq[mm2aX;uJIF{e2G7		M3LiU2lvcGmkaYTpc44hd2ZiaIXtZY4hU0dvMTDj[YxtKGe{b4f0bEBqdiCjIHPlcIwhfmmjYnnsbZR6KGG\|c3H5MmlEPTB;ND62NFg1PSEQvF2=	M4LkOnNCVkeHUh?=
KINGS-1 cell	Mof5S5Jwf3SqIHnubIljcXSrb36gZZN{[Xl?		NX\0RopUUW6qaXLpeIlwdiCxZjDoeY1idiCNSV7HV{0yKGOnbHyg[5Jwf3SqIHnuJIEh[2WubDD2bYFjcWyrdImgZZN{[XlwSVO1NF0xNjF4Nk[2JO69VQ>?	MYPTRW5ITVJ?
LXF-289 cell	MVrHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>?		MX\Jcohq[mm2aX;uJI9nKGi3bXHuJGxZTi1{OEmgZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfU5KSzVyPUCuNFM6PTZizszN	M1\jenNCVkeHUh?=
MC116 cell	MoLIS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl?		NG\JdnNKdmirYnn0bY9vKG:oIHj1cYFvKE2FMUG2JINmdGxiZ4Lve5RpKGmwIHGgZ4VtdCC4aXHibYxqfHliYYPzZZkvUUN3ME2wMlEyPDFizszN	MWHTRW5ITVJ?
KS-1 cell	NF\POIxIem:5dHigbY5pcWKrdHnvckBie3OjeR?=		MonJTY5pcWKrdHnvckBw\iCqdX3hckBMWy1zIHPlcIwh\3Kxd4ToJIlvKGFiY3XscEB3cWGkaXzpeJkh[XO\|YYmuTWM2OD1yLkCyO\|Mh\|ryP	M37Be3NCVkeHUh?=
KU812 cell	NGPUe\|JIem:5dHigbY5pcWKrdHnvckBie3OjeR?=		MmLQTY5pcWKrdHnvckBw\iCqdX3hckBMXThzMjDj[YxtKGe{b4f0bEBqdiCjIHPlcIwhfmmjYnnsbZR6KGG\|c3H5MmlEPTB;MD6xNVg5OyEQvF2=	MYrTRW5ITVJ?
MEG-01 cell	MUXHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>?		MnH3TY5pcWKrdHnvckBw\iCqdX3hckBOTUdvMEGgZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfU5KSzVyPUCuNFAxODB7OEC1JO69VQ>?	MYPTRW5ITVJ?
MFH-ino cell	NYfGZmhzT3Kxd4ToJIlvcGmkaYTpc44h[XO\|YYm=		MofyTY5pcWKrdHnvckBw\iCqdX3hckBOTkhvaX7vJINmdGxiZ4Lve5RpKGmwIHGgZ4VtdCC4aXHibYxqfHliYYPzZZkvUUN3ME2wMlA1PzJ2IN88US=>	NF75codUSU6JRWK=
L-540 cell	NHrOSI5Iem:5dHigbY5pcWKrdHnvckBie3OjeR?=		MkjCTY5pcWKrdHnvckBw\iCqdX3hckBNNTV2MDDj[YxtKGe{b4f0bEBqdiCjIHPlcIwhfmmjYnnsbZR6KGG\|c3H5MmlEPTB;MUWuNFY4OSEQvF2=	Ml;kV2FPT0WU
MHH-NB-11 cell	MUXHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>?		MVnJcohq[mm2aX;uJI9nKGi3bXHuJG1JUC2QQj2xNUBk\WyuIHfyc5d1cCCrbjDhJINmdGxidnnhZoltcXS7IHHzd4F6NkmFNUC9OFMvODhzODFOwG0>	MkKxV2FPT0WU
MMAC-SF cell	M{n0SGdzd3e2aDDpcohq[mm2aX;uJIF{e2G7		NFq5XoxKdmirYnn0bY9vKG:oIHj1cYFvKE2PQVOtV2Yh[2WubDDndo94fGhiaX6gZUBk\WyuII\pZYJqdGm2eTDhd5NigS6LQ{WwQVgvPzl\|MEeg{txO	M1\LZ3NCVkeHUh?=
LB2241-RCC cell	Ml32S5Jwf3SqIHnubIljcXSrb36gZZN{[Xl?		MojyTY5pcWKrdHnvckBw\iCqdX3hckBNSjJ{NEGtVmNEKGOnbHyg[5Jwf3SqIHnuJIEh[2WubDD2bYFjcWyrdImgZZN{[XlwSVO1NF06NjB{MEGyJO69VQ>?	NFHEWJdUSU6JRWK=
LB831-BLC cell	MYfHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>?		MofBTY5pcWKrdHnvckBw\iCqdX3hckBNSjh\|MT3CUGMh[2WubDDndo94fGhiaX6gZUBk\WyuII\pZYJqdGm2eTDhd5NigS6LQ{WwQVAvODR4MEmg{txO	MXHTRW5ITVJ?
MOLT-16 cell	Mo\VS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl?		NH\vcnRKdmirYnn0bY9vKG:oIHj1cYFvKE2RTGStNVYh[2WubDDndo94fGhiaX6gZUBk\WyuII\pZYJqdGm2eTDhd5NigS6LQ{WwQVI6NjZ{OUKg{txO	NVjnWGxTW0GQR1XS
LC-1F cell	Mo\PS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl?		MVTJcohq[mm2aX;uJI9nKGi3bXHuJGxENTGIIHPlcIwh\3Kxd4ToJIlvKGFiY3XscEB3cWGkaXzpeJkh[XO\|YYmuTWM2OD1{Nz6zNlQ2KM7:TR?=	NYD5WHZPW0GQR1XS
MOLT-4 cell	MXHHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>?		MV\Jcohq[mm2aX;uJI9nKGi3bXHuJG1QVFRvNDDj[YxtKGe{b4f0bEBqdiCjIHPlcIwhfmmjYnnsbZR6KGG\|c3H5MmlEPTB;Mk[uOlc2OyEQvF2=	M{\vV3NCVkeHUh?=
MZ1-PC cell	NEnQUmZIem:5dHigbY5pcWKrdHnvckBie3OjeR?=		MYHJcohq[mm2aX;uJI9nKGi3bXHuJG1bOS2SQzDj[YxtKGe{b4f0bEBqdiCjIHPlcIwhfmmjYnnsbZR6KGG\|c3H5MmlEPTB;MD6wN\|EyQSEQvF2=	MkG0V2FPT0WU
MONO-MAC-6 cell	MmnvS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl?		MnrvTY5pcWKrdHnvckBw\iCqdX3hckBOV06RLV3BR{03KGOnbHyg[5Jwf3SqIHnuJIEh[2WubDD2bYFjcWyrdImgZZN{[XlwSVO1NF05NjJ5ME[2JO69VQ>?	MYjTRW5ITVJ?
MZ2-MEL cell	MUnHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>?		MorDTY5pcWKrdHnvckBw\iCqdX3hckBOYjJvTVXMJINmdGxiZ4Lve5RpKGmwIHGgZ4VtdCC4aXHibYxqfHliYYPzZZkvUUN3ME2wMlI5PTN5IN88US=>	MWDTRW5ITVJ?
MPP-89 cell	NI\4NGRIem:5dHigbY5pcWKrdHnvckBie3OjeR?=		MVjJcohq[mm2aX;uJI9nKGi3bXHuJG1RWC16OTDj[YxtKGe{b4f0bEBqdiCjIHPlcIwhfmmjYnnsbZR6KGG\|c3H5MmlEPTB;MD6wOFA1QSEQvF2=	MYLTRW5ITVJ?
MZ7-mel cell	MkP0S5Jwf3SqIHnubIljcXSrb36gZZN{[Xl?		M33NeWlvcGmkaYTpc44hd2ZiaIXtZY4hVVp5LX3lcEBk\WyuIHfyc5d1cCCrbjDhJINmdGxidnnhZoltcXS7IHHzd4F6NkmFNUC9NE41PzlzMTFOwG0>	M1f3V3NCVkeHUh?=
LOXIMVI cell	M4j6ZWdzd3e2aDDpcohq[mm2aX;uJIF{e2G7		NGjScoZKdmirYnn0bY9vKG:oIHj1cYFvKEyRWFnNWmkh[2WubDDndo94fGhiaX6gZUBk\WyuII\pZYJqdGm2eTDhd5NigS6LQ{WwQVAvOzF3MEOg{txO	MVnTRW5ITVJ?
NALM-6 cell	NWLa[mdlT3Kxd4ToJIlvcGmkaYTpc44h[XO\|YYm=		M1;kVGlvcGmkaYTpc44hd2ZiaIXtZY4hVkGOTT22JINmdGxiZ4Lve5RpKGmwIHGgZ4VtdCC4aXHibYxqfHliYYPzZZkvUUN3ME2wMlE6Ojl3IN88US=>	NUHVW45xW0GQR1XS
NB13 cell	M3\jfWdzd3e2aDDpcohq[mm2aX;uJIF{e2G7		NWfaSYZ4UW6qaXLpeIlwdiCxZjDoeY1idiCQQkGzJINmdGxiZ4Lve5RpKGmwIHGgZ4VtdCC4aXHibYxqfHliYYPzZZkvUUN3ME2xPU41QDd5IN88US=>	M{\WSHNCVkeHUh?=
NB5 cell	MUHHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>?		M3r1[2lvcGmkaYTpc44hd2ZiaIXtZY4hVkJ3IHPlcIwh\3Kxd4ToJIlvKGFiY3XscEB3cWGkaXzpeJkh[XO\|YYmuTWM2OD1zLkO5PFI4KM7:TR?=	MYrTRW5ITVJ?
NB17 cell	MnvOS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl?		MX\Jcohq[mm2aX;uJI9nKGi3bXHuJG5DOTdiY3XscEBoem:5dHigbY4h[SClZXzsJJZq[WKrbHn0fUBie3OjeT7JR\|UxRTNwNkO4OFch\|ryP	NHPR[2FUSU6JRWK=
NCCIT cell	NWLMPJAxT3Kxd4ToJIlvcGmkaYTpc44h[XO\|YYm=		NYO5Znd[UW6qaXLpeIlwdiCxZjDoeY1idiCQQ1PJWEBk\WyuIHfyc5d1cCCrbjDhJINmdGxidnnhZoltcXS7IHHzd4F6NkmFNUC9Nk45PjZzNjFOwG0>	NVnVWVhiW0GQR1XS
NB69 cell	MljSS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl?		NEToOodKdmirYnn0bY9vKG:oIHj1cYFvKE6ENkmgZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfU5KSzVyPUCuNVQ1OzZizszN	NF;WUGVUSU6JRWK=
NCI-H1304 cell	M33jPWdzd3e2aDDpcohq[mm2aX;uJIF{e2G7		NVfNcoZUUW6qaXLpeIlwdiCxZjDoeY1idiCQQ1mtTFE{ODRiY3XscEBoem:5dHigbY4h[SClZXzsJJZq[WKrbHn0fUBie3OjeT7JR\|UxRTJ6LkG2Nlgh\|ryP	MXLTRW5ITVJ?
NCI-H1395 cell	NH3kbnJIem:5dHigbY5pcWKrdHnvckBie3OjeR?=		NVzWdmxsUW6qaXLpeIlwdiCxZjDoeY1idiCQQ1mtTFE{QTViY3XscEBoem:5dHigbY4h[SClZXzsJJZq[WKrbHn0fUBie3OjeT7JR\|UxRTR{LkCxOlMh\|ryP	M3[xR3NCVkeHUh?=
MHH-PREB-1 cell	Ml\qS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl?		M1HCbmlvcGmkaYTpc44hd2ZiaIXtZY4hVUiKLWDSSWIuOSClZXzsJIdzd3e2aDDpckBiKGOnbHygeoli[mmuaYT5JIF{e2G7LlnDOVA:OC55NES2PUDPxE1?	MUTTRW5ITVJ?
MLMA cell	M2HBO2dzd3e2aDDpcohq[mm2aX;uJIF{e2G7		M37iRWlvcGmkaYTpc44hd2ZiaIXtZY4hVUyPQTDj[YxtKGe{b4f0bEBqdiCjIHPlcIwhfmmjYnnsbZR6KGG\|c3H5MmlEPTB;MD6xOFA{OiEQvF2=	NEWzb\|ZUSU6JRWK=
MN-60 cell	MoK5S5Jwf3SqIHnubIljcXSrb36gZZN{[Xl?		MlW1TY5pcWKrdHnvckBw\iCqdX3hckBOVi14MDDj[YxtKGe{b4f0bEBqdiCjIHPlcIwhfmmjYnnsbZR6KGG\|c3H5MmlEPTB;MUWuNVk4QSEQvF2=	NVfYe\|diW0GQR1XS
MV-4-11 cell	M{eyc2dzd3e2aDDpcohq[mm2aX;uJIF{e2G7		M2PSXGlvcGmkaYTpc44hd2ZiaIXtZY4hVVZvND2xNUBk\WyuIHfyc5d1cCCrbjDhJINmdGxidnnhZoltcXS7IHHzd4F6NkmFNUC9OE4{PjR3NDFOwG0>	M{nSUnNCVkeHUh?=
NB6 cell	NYnhRopMT3Kxd4ToJIlvcGmkaYTpc44h[XO\|YYm=		M4e1OWlvcGmkaYTpc44hd2ZiaIXtZY4hVkJ4IHPlcIwh\3Kxd4ToJIlvKGFiY3XscEB3cWGkaXzpeJkh[XO\|YYmuTWM2OD17LkmyNlU6KM7:TR?=	MmHaV2FPT0WU
NCI-H1355 cell	NV;zWoVNT3Kxd4ToJIlvcGmkaYTpc44h[XO\|YYm=		NWLxfFI6UW6qaXLpeIlwdiCxZjDoeY1idiCQQ1mtTFE{PTViY3XscEBoem:5dHigbY4h[SClZXzsJJZq[WKrbHn0fUBie3OjeT7JR\|UxRTBwMUGwNlgh\|ryP	M1fDc3NCVkeHUh?=

Click to View More Cell Line Experimental Data

Assay

Methods	Test Index	PMID

Western blot	phospho-c-Abl(Tyr245) / phospho-c-Src(Tyr416) ; p27 / p21 ; cleaved caspase 3 ; p-FAK/p-STAT3	23049975 20145167 23721490
Growth inhibition assay	Cell viability	23721490
Immunofluorescence	SRC / Met ; α-tubulin ; F-actin / Actinin-4 / Paxillin	26517812 31053734
ELISA	TNF-α ; E-selectin ; VCAM-1	17684099 31110200

In vivo

Dasatinib reverses splenomegaly in LMP2A/MYC double transgenic mice. Dasatinib specifically prevents colony formation by LMP2A expressing bone marrow B cells and decreased spleen size in the TgE mice. Spleen mass is significantly decreased among Dasatinib treated Tg6/λ-MYC mice when compared to the control group. Dasatinib inhibits lymphadenopathy in LMP2A/MYC double transgenic mice. Dasatinib reverses splenomegaly in Rag1KO mice engrafted with tumor cells from LMP2A/MYC double transgenic mice. Dasatinib therapy inhibits Lyn phosphorylation in B lymphocyte tumors expressing LMP2A. ^[3]

Protocol (from reference)

Kinase Assay: ^[1]	Kinase autophosphorylation assays: Kinase assays using wild-type and mutant glutathione S-transferase (GST)-Abl fusion proteins (c-Abl amino acids 220-498) are done. GST-Abl fusion proteins are released from glutathione-Sepharose beads before use; the concentration of ATP is 5 μM. Immediately before use in kinase autophosphorylation and in vitro peptide substrate phosphorylation assays, GST-Abl kinase domain fusion proteins are treated with LAR tyrosine phosphatase. After 1-hour incubation at 30 °C, LAR phosphatase is inactivated by addition of sodium vanadate (1 mM). Immunoblot analysis comparing untreated GST-Abl kinase to dephosphorylated GST-Abl kinase is routinely done using phosphotyrosine-specific antibody 4G10 to confirm complete (>95%) dephosphorylation of tyrosine residues and c-Abl antibody CST 2862 to confirm equal loading of GST-Abl kinase. The Dasatinib concentration range is extended to 1,000 nM for mutant T315I. These same inhibitor concentrations are used for the in vitro peptide substrate phosphorylation assays. The three inhibitors are tested over these same concentration ranges against GST-Src kinase and GST-Lyn kinase.
Cell Research: ^[1]	Cell lines: Ba/F3 cell lines Concentrations: ~32 nM Incubation Time: 72 hours Method: Ba/F3 cell lines are seeded in triplicate and incubated with escalating concentrations of Dasatinib for 72 hours. Proliferation is measured using a methanethiosulfonate-based viability assay. IC50 and IC90 values are reported as the mean of three independent experiments done in quadruplicate. The inhibitor concentration ranges are 0 nM to 32 nM (Dasatinib). The Dasatinib concentration range is extended to 200 nM for mutant T315I.
Animal Research: ^[3]	Animal Models: EμLMP2A (TgE and Tg6 strains), MYC (λ-MYC), and LMP2A/λ-MYC double transgenic mice (Tg6/λ-MYC) Dosages: 30 mg/kg Administration: Administered via i.p.

References

[4] Dargart JL, et al. Antiviral Res. 2012, 95(1), 49-56.

+ Expand

Solubility (25°C)

In vitro


In vivo	Add solvents to the product individually and in order (Data is from Selleck tests instead of citations): 2% DMSO+30% PEG 300+dd H2O For best results, use promptly after mixing. Click to purchase: PEG300	5mg/mL

Chemical Information

Molecular Weight	506.02
Formula	C₂₂H₂₈ClN₇O₃S
CAS No.	863127-77-9
Storage	3 years	-20°C	powder
Storage	2 years	-80°C	in solvent
Smiles	CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO.O

Download Dasatinib Monohydrate SDF

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

Dosage: mg/kg Average weight of animals: g Dosing volume per animal:μL Number of animals:

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO + % + % Tween 80 + % ddH₂O

%DMSO+ %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH₂O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Molarity Calculator

Mass	Concentration	Volume	Molecular Weight
=	×	×

Dilution Calculator Molecular Weight Calculator

Clinical Trial Information

NCT Number	Recruitment	Interventions	Conditions	Sponsor/Collaborators	Start Date	Phases
NCT04925648	Recruiting	Drug: Dasatinib\|Drug: Darolutamide	Metastatic Prostate Cancer	St Vincent''s Hospital Sydney	October 18 2021	Phase 2
NCT04933526	Not yet recruiting	Drug: Flumatinib\|Drug: Dasatinib	Chronic Myeloid Leukemia in Chronic Phase	Shenzhen Second People''s Hospital	July 1 2021	Phase 4
NCT04063124	Recruiting	Drug: Dasatinib + Quercetin	Alzheimer Disease	The University of Texas Health Science Center at San Antonio\|Mayo Clinic	February 14 2020	Phase 1\|Phase 2
NCT04155411	Recruiting	Drug: Dasatinib	Dasatinib\|BCR-ABL\|Chronic Myeloid Leukemia	Shenzhen Second People''s Hospital	December 1 2019	Phase 4

(data from https://clinicaltrials.gov, updated on 2022-01-17)

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Frequently Asked Questions

Question 1:
What’s the difference between S1021 and S7782?

Answer:
Usually, hydrate will be more stable and dissolve better than free base. But this compound (S1021) dissolves better in DMSO than hydrate one (S7782).

C1=C0/X	C1:	LOG(C1):
C2=C1/X	C2:	LOG(C2):
C3=C2/X	C3:	LOG(C3):
C4=C3/X	C4:	LOG(C4):
C5=C4/X	C5:	LOG(C5):
C6=C5/X	C6:	LOG(C6):
C7=C6/X	C7:	LOG(C7):
C8=C7/X	C8:	LOG(C8):